Corcept Therapeutics CORT
NASDAQ CORT
$116.23 +2.21 (+1.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Selling, General & Administrative (2010 - 2026)

Updated

Corcept Therapeutics (CORT) recorded Selling, General & Administrative of $156.9 million in Q2 2026, up 51.1% from $103.85 million a year earlier and up 7.9% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a TTM basis, Corcept Therapeutics' Selling, General & Administrative came in at $556.47 million as of Jun 30, 2026, up 58.3% year-over-year; for FY2025, it was $448.73 million, up 60.1% from FY2024.

  • Annual Selling, General & Administrative has increased for 16 straight years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $280.32 million in FY2024 (+52.1%), $184.26 million in FY2023 (+20.6%), $152.85 million in FY2022 (+24.9%) and $122.36 million in FY2021 (+16.2%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • On a year-over-year basis, Selling, General & Administrative has increased for 22 consecutive quarters, with growth averaging 61.5% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 11.4% (Q4 2023) to 76.8% (Q4 2024).
  • Per Business Quant, the preceding three quarters came in at $145.36 million (Q1 2026), $130.24 million (Q4 2025) and $123.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Corcept Therapeutics 12.33 Bn 10.89 Bn 252.09 Mn 156.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.90 Mn
Mar 31, 2026 145.36 Mn
Dec 31, 2025 130.24 Mn
Sep 30, 2025 123.98 Mn
Jun 30, 2025 103.85 Mn
Mar 31, 2025 90.66 Mn
Dec 31, 2024 83.37 Mn
Sep 30, 2024 73.75 Mn
Jun 30, 2024 66.94 Mn
Mar 31, 2024 56.27 Mn
Dec 31, 2023 47.15 Mn
Sep 30, 2023 45.26 Mn
Jun 30, 2023 43.28 Mn
Mar 31, 2023 48.56 Mn
Dec 31, 2022 42.32 Mn
Sep 30, 2022 35.16 Mn
Jun 30, 2022 37.81 Mn
Mar 31, 2022 37.55 Mn
Dec 31, 2021 32.29 Mn
Sep 30, 2021 30.53 Mn
API Access

Corcept Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CORT&period=max&api_key=YOUR_API_KEY